Lymphatic mapping and sentinel lymph node biopsy in the staging of melanoma

Surgical Oncology

Volumn 7, Issue 1-2, 1998, Pages 51-57

  Edwards, Michael J ^a   Martin, Kimmery D ^b   McMasters, Kelly M ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Lymphatic mapping; Lymphoscintigraphy; Melanoma; Sentinel lymph node

Indexed keywords

DYE; RECOMBINANT ALPHA2B INTERFERON; TECHNETIUM SULFUR COLLOID TC 99M;

ACCURACY; CANCER ADJUVANT THERAPY; CANCER STAGING; EXPERIENCE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MELANOMA; PRIORITY JOURNAL; REVIEW;

EID: 0032452589     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(98)00023-1     Document Type: Review

References (26)

1. [1] Reintgen D, Cruse CW, Wells K et al. The orderly progression of melanoma nodal metastases. Annals of Surgery 1994;220:59-67.
2. [2] Gershenwald JE, Thompson W, Bouvet M et al. Improved sentinel lymph node (SLN) localization in primary melanoma PTAs with use of radiolabelled colloid. Surgery 1998;124:203-10.
3. [3] Spratt JS Jr, Shieber W, Dillard BM, editors. Anatomy and surgical technique of groin dissection. St. Louis: CV Mosby Company, 1965.
4. [4] Mastrangelo M, Baker AR, Katz HR. Cutaneous melanoma. In: DeVita VT Jr, editor. Cancer: principles and practice of oncology, second ed. Philadelphia: JB Lippincott, 1985:1371-422.
5. [5] Polk HC Jr, Cohn JD, Clarkson JG. An appraisal of elective regional lymphadenectomy for melanoma. Current topics in surgical research. New York: Academic Press, 1969:121-32.
6. [6] Polk HC Jr, Linn BS. Selective regional lymphadenectomy For melanoma: a mathematical ad to clinical judgement. Ann Surg 1971;174:402-13.
7. [7] Veronesi U, Adamus J, Bandiera DC et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-30.
8. [8] Balch CM, Soong SJ, Bartolucci AA et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Annals of Surgery 1996;224:255-66.
9. [9] Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. Journal of Clincal Oncology 1988;6:163-72.
10. [10] Joseph E, Brobeil A, Glass F et al. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Annals of Surgical Oncology 1998;5:119-25.
11. [11] Sherman A, Ter-Pogossian M. Lymph node concentration of radioactive colloidal gold following interstitial injection. Cancer 1953;6:1238-40.
12. [12] Alazraki N. Lymphoscintigraphy and the intraoperative gamma probe. Journal of Nuclear Medicine 1995;36:1780-83.
13. [13] Leong SP, Steinmetz I, Habib F.A. et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Archives of Surgery 1997;132:666-73.
14. [14] Norman J, Cruse CW, Espinosa C. et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. American Journal of Surgery 1991;162:432-7.
15. [15] Mudun A, Murray DR, Herda SC et al. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperativc gamma probe. Radiology 1996;119:171-5.
16. [16] Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1997;39:456-66.
17. [17] Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early melanoma. Archives of Surgery 1992;127:392-9.
18. [18] Ross MI, Reintgen D, Balch CM. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Seminar on Surgical Oncology 1993;9:219-23.
19. [19] Alex JC. Krag DN. Gamma-probe guided localization of lymph nodes Surgical Oncology 1993;2:137-43.
20. [20] Albertini JJ, Cruse WC, Rapaport D et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. American Surgery 1996;223:217-24.
21. [21] Thompson W, Gershenwald J, Lee J et al. Sentinel lymph node identification in melanoma patients using two techniques: dye vs. dye + radioactive colloid. Presented at Cancer Symposium, Society of Surgical Oncology. Atlanta, Georgia, 21-24 March 1996.
22. [22] Heller R, King B, Backey P, Cruse W, Reintgen D. Identification of submicroscope lymph node metastases in patients with malignant melanoma. Seminars on Surgical Oncology 1993;9:285-9.
23. [23] Balch CM. Surgical management of regional lymph nodes in cutaneous melanoma. Journal of American Academy of Dermatology 1980;3:511-24.
24. [24] Mellado B, Colomer D, Castel T el al. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. Journal of Clinical Oncology 1996;14:2091-97.
25. [25] Miliotes G, Albertini J, Berman C et al. The tumor biology of melanoma nodal metastases. Annals of Surgery 1996;62:81-8.
26. [26] Kirkwood JM, Strawderman MH, Ernstoff MS et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. Journal of Clinical Oncology 1996;14:7-17.